Remove Healthcare Remove Networking Remove Pharmaceutical manufacturing Remove Transportation
article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

Linked to talent, the presence of good universities is another great sign for life sciences, especially institutions with a focus on healthcare. Domestic market and transportation infrastructure. Locations with access to the sea may also offer a cheaper way of transporting goods. Industry clusters.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

With the myriad of guidance and recommendations to boost diversity and inclusion in oncology trials, , biotech and pharmaceutical manufacturers are left to interpret the criteria and implement them through tangible action. J National Comprehensive Cancer Network. 2019;17(11):1309-1316. doi:10.6004/jnccn.2019.7321

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We Previously he was with Accenture where he led large teams in outsourcing projects across Europe and US for clients in the transportation and retail businesses. Chiesi’s philosophy in action.